Cited by 376Hormonal Regulation and HypertensionRenin-Angiotensin System StudiesAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis

Huby, Anne-Cécile, Antonova, Galina, Groenendyk, Jake, Gomez-Sanchez, Celso E., Bollag, Wendy B., Filosa, Jessica A., de Chantemèle, Eric J. Belin·2015·Circulation

DOI 10.1161/circulationaha.115.018226

Open this paper in CoChat — free account

Abstract

BACKGROUND: In obesity, the excessive synthesis of aldosterone contributes to the development and progression of metabolic and cardiovascular dysfunctions. Obesity-induced hyperaldosteronism is independent of the known regulators of aldosterone secretion, but reliant on unidentified adipocyte-derived factors. We hypothesized that the adipokine leptin is a direct regulator of aldosterone synthase (CYP11B2) expression and aldosterone release and promotes cardiovascular dysfunction via aldosterone-dependent mechanisms. METHODS AND RESULTS: Immunostaining of human adrenal cross-sections and adrenocortical cells revealed that adrenocortical cells coexpress CYP11B2 and leptin receptors. Measurements of adrenal CYP11B2 expression and plasma aldosterone levels showed that increases in endogenous (obesity) or exogenous (infusion) leptin dose-dependently raised CYP11B2 expression and aldosterone without elevating plasma angiotensin II, potassium or corticosterone. Neither angiotensin II receptors blockade nor α and β adrenergic receptors inhibition blunted leptin-induced aldosterone secretion. Identical results were obtained in cultured adrenocortical cells. Enhanced leptin signaling elevated CYP11B2 expression and plasma aldosterone, whereas deficiency in leptin or leptin receptors blunted obesity-induced increases in CYP11B2 and aldosterone, ruling out a role for obesity per se. Leptin increased intracellular calcium, elevated calmodulin and calmodulin-kinase II expression, whereas calcium chelation blunted leptin-mediated increases in CYP11B2, in adrenocortical cells. Mineralocorticoid receptor blockade blunted leptin-induced endothelial dysfunction and increases in cardiac fibrotic markers. CONCLUSIONS: Leptin is a newly described regulator of aldosterone synthesis that acts directly on adrenal glomerulosa cells to increase CYP11B2 expression and enhance aldosterone production via calcium-dependent mechanisms. Furthermore, leptin-mediated aldosterone secretion contributes to cardiovascular disease by promoting endothelial dysfunction and the expression of profibrotic markers in the heart.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.018226

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PTP1B Regulates Leptin Signal Transduction In Vivo
Zabolotny, J. M., Bence, K. K., Stricker‐Krongrad, A., Haj, F. G., Wang, Y., Minokoshi, Y., Kim, Y., Elmquist, J. K., Tartaglia, L. A., Kahn, B. B., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00148-x · Cited by 818
Human Leptin Deficiency Caused by a Missense Mutation: Multiple Endocrine Defects, Decreased Sympathetic Tone, and Immune System Dysfunction Indicate New Targets for Leptin Action, Greater Central than Peripheral Resistance to the Effects of Leptin, and Spontaneous Correction of Leptin-Mediated Defects
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Cardiac remodeling in obesity
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B
Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., Kennedy, B. P., & Tremblay, M. L. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00149-1 · Cited by 545
Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart‐Bornstein, M., Lamounier‐Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 442
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction
Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190223 · Cited by 375
Sixteen years and counting: an update on leptin in energy balance
Gautron, L., & Elmquist, J. K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45888 · Cited by 367
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351

Show all 49 references

Research works printed but not linked: 2

10.1161/01.HYP.0000231338.41548.fc · DOI · Paper page
10.1161/01.HYP.0000253258.36141.c7 · DOI

Sorted by citations

Items 301–374 of 374

Role of Mineralocorticoid Receptors in Cardiovascular Disease
Elton-Bott, N., Cole, T. J., & Young, M. J. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26235 · Cited by 2
Unveiling the role of aldosterone in metabolic dysfunction–associated steatotic liver disease
Hernández‐Rubio, A., Julián, M. T., Valassi, E., Alonso, N., & Puig‐Domingo, M. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10056-3 · Cited by 1
Mechanisms for Mineralocorticoid-Driven Age-Related Hypertension: Potential Therapeutic Role of Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors
Golec, S., Vaidya, A., Pitt, B., & Jaffe, I. Z. (2026) · Circulation Research · doi:10.1161/circresaha.126.327593 · Cited by 1
Salivary hormones and adipokines are associated with glycemic control and early renal and cardiometabolic markers in children and young adults with type 1 diabetes
Robino, A., Tornese, G., Aldegheri, L., Franceschi, R., Mozzillo, E., Candia, F. D., Morosini, C., Zanfardino, A., Delvecchio, M., Bombaci, B., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-03038-4 · Cited by 1
Fat and Fibrosis
Mao, R., & Coffey, J. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_7 · Cited by 1
Renal mineralocorticoid receptor expression is reduced in lipoatrophy
Toffoli, B., Bernardi, S., Winkler, C., Carrascosa, C., Gilardi, F., & Desvergne, B. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12579 · Cited by 1
The Relationship between Obesity, Insulin Resistance and Aldosterone Levels
Mazzuco, T. L. (2018) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2018.06.555680 · Cited by 1
Classic endocrine disorders: implications for cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00014-0 · Cited by 1
The Insight into the Role of Leptin and Its Receptor in Heart Failure with Preserved Ejection Fraction
Zabojska, K., Cygnarowicz, A., Wojtas, A. K., Korotko, U., Mandziuk, A., Witowska, K., Turemka, M., Biskupski, M., Hosseinnejad, N., & Sacher, K. (2024) · Quality in Sport · doi:10.12775/qs.2024.35.56489 · Cited by 1
Obesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect
Owen, J., Morse, S., McLean, A., & Reisin, E. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_15 · Cited by 1
Obesity-Induced Cardiovascular Complications and Therapeutic Intervention
Alam, M. J., & Banerjee, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_2 · Cited by 2
Neurohormonal and metabolic profile of heart failure in obese versus non-obese patients
Miyazaki, K., Namba, T., Hakuno, D., & Adachi, T. K. (2020) · Vascular Failure · doi:10.30548/vascfail.4.1_16 · Cited by 1
Adipositas und HFpEF – Henne oder Ei?
Kresoja, K., Rommel, K., Thiele, H., & Lurz, P. C. (2021) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-1325-7517 · Cited by 1
Metabolic status, ultrasound changes of liver and vascular artery wall in men with abdominal obesity
Serdyukov, D. Y., Гордиенко, А. В., Жирков, И. И., Fedorova, A. S., Sokolov, D. A., Dyidyishko, V. T., Апалько, С. В., & Scherbak, S. G. (2020) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma25963 · Cited by 1
Regulation of Aldosterone Production
Monticone, S., Rainey, W. E., Bollag, W. B., & Isales, C. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00025-8 · Cited by 1
UDCA and INT-777 suppress cardiac fibrosis triggered by IL-11 through involvement of TGR5Preprint
Reilly-O’Donnell, B., Ferraro, E., Tikhomirov, R., Núñez-Toldrà, R., Shchendrygina, A., Patel, L., Wu, Y., Mitchell, A., Endo, A., Adorini, L., et al. (2022) · medRxiv · doi:10.1101/2022.05.11.22274945 · Cited by 1
Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and AdiposityPreprint
Tsai, C., Chan, J. M., Milks, J., Ferrebus, A., Hanna, I., Mahrokhian, S., Newman, A. J., Stéfanie, P.-L. S., Marques, I. R., Foote, K., et al. (2025) · medRxiv · doi:10.1101/2025.11.12.25340075 · Cited by 1
Recettore mineralcorticoide e organo adiposo: implicazioni cliniche e terapeutiche
Caprio, M., Infante, M., Armani, A., Lenzi, A., & Fabbri, A. (2016) · L Endocrinologo · doi:10.1007/s40619-016-0179-9
Aldosterone’s Mechanism of Action
Baudrand, R. F., Pojoga, L. H., & Romero, J. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00010-6
Anti-hypertensive and cardioprotective effects of buchu
Huisamen, B. (2019) · doi:10.4102/aosis.2019.bk84.05
Mineralocorticoid Receptor and Leptin: A Dangerous Liaison in the Obese Heart
Marín‐Royo, G., Luaces, M., Cachofeiro, V., & Martínez‐Martínez, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87236
Mineralocorticoid Receptor in Novel Target Tissues: A Closer Look at the Adipocyte
Armani, A., Marzolla, V., Feraco, A., Gorini, S., Mammi, C., Infante, M., & Caprio, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87231
Mechanisms underlying vascular stiffening in obesity, insulin resistance, and type 2 diabetes
Hill, M. A., Yang, Y., Sun, Z., Zhang, L., & Sowers, J. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821070-3.00021-0
Abdominal obesity and adipocyte metabolic activity: criteria for "health" and "neutrality"
Serdyukov, D. Y., Гордиенко, А. В., Sokolov, D. A., Дыдышко, В. Т., & Жирков, И. И. (2021) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma71312
[Hypoparathyroidism--classification, differential diagnosis, and therapy].
Honjo, A., Suematsu, T., Kuroda, M., & Takeda, R. (1982) · PubMed
Microvascular effects of aldosterone and salt in health, obesity and hypertension
Sch�tten (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190620ms
Pathophysiology of Bone and Cardiac Involvement in Spondyloarthropathies: The indispensible value of magnetic resonance imaging
Mavrogeni, S. I., Nikas, I., Bonou, M., & Kitas, G. D. (2021) · Trends in Medicine · doi:10.15761/tim.1000282
Einfluss einer fettreichen Ernährung auf eine funktionelle Einzelniere mit den Risiko-Genvarianten COL4A3 +/- und NPHS +/R140Q im Mausmodell
Breier, K. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9555
MR and Aldosterone: From Hydro-Saline Metabolism to Metabolic Diseases
Armani, A., & Caprio, M. (2022) · Endocrinology · doi:10.1007/978-3-030-44628-4_14-1
Primary Aldosteronism
Boulkroun, S., & Zennaro, M. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_13
Research Progress on Related Factors Affecting Elevated Aldosterone Levels
阿达莱提, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122750
Associations of the Body Roundness Index with Prediabetes and Diabetes in American Adults: Cross-Sectional AnalysisPreprint
Song, S., Yin, J., Liu, Y., Li, X., Li, M., Zhang, W., Liu, Y., & Yang, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4792127/v1
Obesity, histone acetylation, and insulin resistance
Dhar, A., Marinkova, D. A., Presley, C., Bagchi, A. K., & Bagchi, R. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18979-1.00007-1
Dietary sodium, mineralocorticoid receptor, and sex differences in endothelial function
Menik, I. M. G., Barris, C. T., & de Chantemèle, E. J. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22266-5.00005-7
Comparative Outcomes in Metabolic Surgery: Diabetes and Cardiovascular Health
Lee, T. C., Flores, R. D. L., Yonge, J. D., & Stroud, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-72309-4_26
ANMCO position paper: diagnosis and treatment of heart failure with preserved systolic function
Iacovoni, A., Navazio, A., Luca, L. D., Gori, M., Corda, M., Milli, M., Iacoviello, M., Lenarda, A. D., Tano, G. D., Marini, M., et al. (2025) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suaf070
Clinical Significance of Skeletal Fat‐to‐Muscle Ratio in Idiopathic Hyperaldosteronism
Jiang, Y., Li, D. X., Cao, C. C., Feng, W., Liu, R., Xu, Y., & Cao, C. (2025) · Clinical Endocrinology · doi:10.1111/cen.15274
Intrarenal Generation of Aldosterone Contributes to Ischemia-Induced Hypertension and Nephropathy in MicePreprint
Fu, Z., Zou, C., Kimball, A. W., & Yang, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.24.671658
Association between the weight-adjusted waist index and type 2 diabetes mellitus: Evidence from the RaNCD study
Fateh, H. L., Bonyani, M., Shakiba, E., Navabi, J., & Pasdar, Y. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.08.007
Weight loss following gastric bypass increases aldosterone reactivity to orthostatic stress in patients with obesity
Zahnd, J., Vakilzadeh, N., Schwotzer, N., Hendriks‐Balk, M., Mantziari, S., Sauser, J., Maillard, M. P., Grouzmann, E., Favre, L., & Wuerzner, G. (2025) · Blood Pressure · doi:10.1080/08037051.2025.2555452
Additional file 1 of Characteristics and correlation of body fat distribution and brachial-ankle pulse wave velocity in adults aged 20–59 years: a cross-sectional study
Wang, S., Shi, H., Luo, L., & He, H. (2024) · Figshare · doi:10.6084/m9.figshare.24934109
Additional file 4 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20056351
Additional file 6 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20056357
Additional file 1 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20056342
Additional file 7 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20056360
Additional file 5 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20056354
Additional file 2 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20056345
Additional file 3 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis
Chen, J., Mei, Z., Yang, Y., Dai, C., Wang, Y., Zeng, R., & Liu, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20056348
Renalase stimulates aldosterone production via PMCA4b/cAMP in NCI-H295R cells
Fu, R., Huang, M., Liu, T., Chen, Y., Li, X., & Jiang, W. (2026) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2610034
Perivascular adipose tissue from female rats fed a high‐fat diet impaired mesenteric artery vasodilation
Sangha, G. S., Sapp, R. M., Weber, C. M., Torbit, D., Rangachar, N., Barnes, A., & Clyne, A. M. (2026) · Physiological Reports · doi:10.14814/phy2.70746 · Cited by 1
Lipoproteins and aldosterone in obesity-associated hypertension
Bollag, W. B. (2026) · Current Opinion in Physiology · doi:10.1016/j.cophys.2026.100924
Contribution à l'étude de l'effet de la substance P sur la sécrétion d'aldostérone dans la glande surrénale humaine normale
Wils, J. (2018) · theses.fr (ABES) · doi:10.70675/9e27a219zc12bz4357z92c7z19b75278e344
Implication du récepteur minéralocorticoïde adipeux dans les dysfonctions métaboliques et vasculaires associées à l’obésité et au syndrome métabolique : rôle des mitochondries
Lefranc, C. (2020) · theses.fr (ABES) · doi:10.70675/63bffb80z502cz4bdcz9729ze61518233589
Interactions vasculaires et hormonales dans l'hyperaldostéronisme primaire
Abdellatif, A. B. (2022) · theses.fr (ABES) · doi:10.70675/5f0b4f73zaca0z4bc4z99d5z8ca373f11d25
Spironolactone in the treatment of heart failure and resitant arterial hypertension
Málek, F. (2026) · Vnitřní lékařství · doi:10.36290/vnl.2026.023
Leptin and cardiovascular health
Pereira, S. X. E. R. L. (2026) · Endocrinology · doi:10.1210/endocr/bqag050
Aldosterone synthase inhibitors for the treatment of cardiovascular disease
Rossi, G. P., Rossi, F. B., Cignarella, A., & Seccia, T. M. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01259-4
Alterations in Cardiac and Systemic Metabolism in Heart Failure
Bertero, E., Capone, F., Costa, A., Maack, C., & Ameri, P. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013766
Heart Failure with Preserved Ejection Fraction Beyond the Myocardium: Systemic Inflammation as the Central Axis of Pathophysiology
Ideta, M. M. L., Nihei, C. M. I., MOREIRA, P. H. B., & de Freitas, A. K. E. (2025) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250043i
Insuficiência Cardíaca Com Fração de Ejeção Preservada Além do Miocárdio: A Inflamação Sistêmica como Eixo Central da Fisiopatologia
Ideta, M. M. L., Nihei, C. M. I., MOREIRA, P. H. B., & de Freitas, A. K. E. (2012) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250043
Heart Failure
Suh, S., & Kindel, T. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-24278-5_60
Dose–response analysis between weight-adjusted waist index and all-cause and cardiovascular mortality: a systematic review and meta-analysis
Yang, P., Huang, N., Ye, J., He, M., Wu, Y. Y., Liu, D., Zhang, H., Chui, P. L., & Liu, Z. H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1766501
Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
Hall, J. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., Mouton, A. J., Wang, Z., & Hall, M. E. (2026) · Clinical Science · doi:10.1042/cs20250039
Breakthrough drugs in the treatment of hypertension-related disease
Hoshide, S., Mogi, M., Shibata, S., Kishi, T., Usui, I., Ando, H., Nakagami, H., Nishiyama, A., Kario, K., & Japanese Society of Hypertension (JSH) Working Group on Emerging Pharmacological Therapies for Hypertension Management (2026) · Hypertension Research · doi:10.1038/s41440-026-02725-2
Cardiac-Adipose Axis in Heart Failure With Preserved Ejection Fraction
Tan, R., Ma, Y. X., Li, N., Zhou, Z., Huang, Z., Liu, T. L., Liao, H., Qin, X., Li, T., & Zhang, C. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.06.006
Aldosterone: mechanisms of normal and impaired regulation and the possibility of their correction in arterial hypertension. Consensus of Russian Medical Society on Arterial Hypertension (RSH) experts
Михайловна, Ч. Н., Blinova, N. V., Trushina, O. I., Podzolkov, V. I., Bragina, A. E., & Chazova, I. E. (2026) · Terapevticheskii arkhiv · doi:10.26442/00403660.2026.07.203747 · Cited by 1
Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction
Kobayashi, M., Pitt, B., & Zannad, F. M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag578
Mechanisms of Obesity-Related Kidney Disease: From Adipose Depot Biology to the Chymase–Aldosterone and Ghrelin–Leptin Axes
Hsu, H.-C., Shih, L., Hou, Y., & Lu, K. (2026) · Biomolecules · doi:10.3390/biom16081155
Investigating a Mineralocorticoid Receptor Mediation of an Ultra‐Short Feedback Loop Regulating Aldosterone Production in Humans
Yuan, Y. E., Adler, G. K., ROSNER, B. A., Merino, A. A., Guzelce, E. C., Williams, G. H., Williams, J. S., & Haas, A. V. (2026) · Clinical Endocrinology · doi:10.1111/cen.70189
Regulation of the Mineralocorticoid Receptor in Physiology and Disease
Young, M. J., Fuller, P. J., Meijer, O. C., Cole, T. J., Kanki, M., Yang, J., Ho, Q. V., Karthigan, N., & Heanue, S. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100156
Clinical and Biochemical Features Associated with Coexisting Primary Aldosteronism in Patients with Obstructive Sleep Apnea: A Cross-Sectional Study
Li, M., Chen, X., Zhang, Y., Teng, Y., Huang, B., Tan, M., Liu, Z., Guo, M., Li, C., Su, X., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16162565
Defining the potential role of the mineralocorticoid receptor in musculoskeletal health and bone crosstalk with other tissues
Bensreti, H., Shaver, J. C., Yearwood, C. L., Alhamad, D. W., Morey, E. C., Sultana, S., Hamrick, M. W., Kosmac, K., Bollag, W. B., de Chantemèle, E. J. B., et al. (2026) · Journal of Endocrinology · doi:10.1530/joe-24-0212
Weight-adjusted waist index and risk of cardiovascular and all-cause mortality in chronic kidney disease: NHANES 2005–2018 analysis of 5,381 adults
Wang, Z., Li, X., Zhu, X. F., Hao, Q., Kong, F., & Liu, G. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2718572
Targeting the aldosterone–mineralocorticoid receptor pathway in cardiovascular–kidney–metabolic syndrome
Sánchez‐Bayuela, T., Barrera‐Chimal, J., & Jaisser, F. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01125-6

Authors: Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B.
Affiliations: Augusta University (US)
From Physiology Department, Medical College of Georgia at Georgia Regents University, Augusta (A.-C.H., G.A., J.G., W.B.B., J.A.F., E.J.D.d.C.); Charlie Norwood VA Medical Center, Augusta, GA (W.B.B.); Endocrine Section, G.V. (Sonny) Montgomery VA Medical Center, and University of Mississippi Medical Center, Jackson (C..E.G.-S.).
ORCID: Bollag, Wendy B.
Filosa, Jessica A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2015-12
Volume: 132
Issue: 22
Pages: 2134-2145
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.115.018226
OpenAlex: W2206025985
Cited by: 376
References: 49
Citations by year: 2026: 34 · 2025: 41 · 2024: 37 · 2023: 34 · 2022: 44 · 2021: 32 · 2020: 36 · 2019: 31 · 2018: 37 · 2017: 29 · 2016: 18 · 2015: 1
FWCI: 24.57
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: leptin, aldosterone secretion, CYP11B2, aldosterone synthase, obesity, hyperaldosteronism, adrenal glomerulosa cells, adipokines, endothelial dysfunction, myocardial fibrosis, calcium signaling, calcium/calmodulin-dependent protein kinase II, mineralocorticoid receptor, cardiovascular disease
MeSH terms: Adrenal Cortex, Aldosterone, Animals, Cells, Cultured, Endothelium, Vascular, Female, Fibrosis, Heart Diseases, Humans, Mice, Inbred C57BL, Mice, Obese, Rats, Inbred WKY, Rats, Zucker, Adipocytes, Mice, Knockout, Leptin, Cell Line, Tumor, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks